CYduct Diagnostics Inc (CYDX)

[blueskies]

5ACES I posted some SNDY 2014 info too. Most recently November

Good Luck to you



Jan 10, 2014 - Solos Endoscopy, Inc. (OTC Pink: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the Country, posted an update for the shareholders on OTC Markets.com.

Solos Endoscopy completed the Audit with TUV SUD America this past year, which included a comprehensive review of the Solos Endoscopy's Quality Manual and 28 Quality System Procedures for compliance with the international quality system standard ISO 13485:2003, to the European Union's Medical Device Directive (MDD 93/42/EEC) and to the Canadian Medical Device Regulations (SOR/98-282). Since the completion of the Audit, the Company has been in contact with the representatives from both TUV SUD and Expert Resources and expects to be certified to ISO 13485:2003 in the next few weeks. Certification to ISO 13485:2003 will in turn allow Solos Endoscopy to obtain the CE Mark on the majority of endoscopic instruments including the MammoView® devices.

Solos has several exciting new advances in product development that will change the way minimally invasive procedures are utilized in the medical field in order to treat and prevent disease

Jan 28, 2014 - Solos Endoscopy, Inc. (OTC Pink: SNDY), a provider of quality innovative healthcare instruments to hospitals across the country, is pleased to announce that the Company has received its ISO 13485:2003 Certification from TUV SUD America.

"ISO Certification is an amazing accomplishment for a company our size. I am proud to say that Solos Endoscopy now carries endoscopic instruments that are both FDA approved and ISO Certified," stated Robert Segersten, President of Solos Endoscopy.

Now that Solos Endoscopy is ISO Certified, the Company will begin to focus its sales efforts internationally

Feb 20, 2014 - Solos Endoscopy, Inc. (OTC Pink: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that the company has commenced negotiations with a Canadian distributor to sell its endoscopic instruments including the MammoView® devices in Canada.

The Certification Body of TUV America has certified that Solos Endoscopy has established and is maintaining a quality management system that meets the requirements of the European Union and Canada.

April 30, 2014 - The Company is currently in discussions with Spectrum Medical Market Consultants to act as its regulatory consultant in Canada for its endoscopic instruments including the MammoView® devices.

July 18, 2014 – Presidents Letter - http://www.otcmarkets.com/financialReportViewer?symbol=SNDY&id=123610

Nov 12, 2014 (eTeligis.com via COMTEX) -- BOSTON, MA, United States, via ETELIGIS INC., 11/12/2014 - - BOSTON, MA /ETELIGIS/ Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to Hospitals across the Country, is pleased to announce that the company's MamoView(R) Breast Endoscopy System has shown strong growth over the past 18 months

"Management expects sales of the MamoView(R) to increase in the future as more physicians are trained in the procedure," stated Robert Segersten, President of Solos Endoscopy.

Nov 24, 2014 -- BOSTON, MA, United States, via ETELIGIS INC., 11/24/2014 - - Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that it has been invited to participate at the 8th International Dr. Susan Love Research Foundation Symposium on the Breast.

Blueskies

SNDY